Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Knocking down Myotubularin, a Gene Mutated in Myotubular Myopathy, Results in Transcriptional Up-regulation of Doublecortin.
Muscle Disease/Neuromuscular Junction
(-)
004
Authors/Disclosures
Kinga Tomczak, MD, PhD (Boston Children's Hospital Tic Disorders and Tourette Syndrome Program) Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Tomczak has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Emalex Biosciences, Inc.. Dr. Tomczak has received personal compensation in the range of $0-$499 for serving as a Consultant for Frazier Life Sciences. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Tomczak has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Advances. Dr. Tomczak has received personal compensation in the range of $0-$499 for serving as a Consultant for Alpha Sights. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Expert Connect. Dr. Tomczak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Emalex Biosciences, Inc.. The institution of Dr. Tomczak has received research support from Emalex Biosciences, Inc.. The institution of Dr. Tomczak has received research support from Noema Pharma.
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file